Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker

por Naccache, Raphael, Belkouchi, Younes, Lawrance, Littisha, Benatsou, Baya, Hadchiti, Joya, Cournede, Paul-Henry, Ammari, Samy, Talbot, Hugues, Lassau, Nathalie
Publicado 2022

Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs

por Decazes, Pierre, Ammari, Samy, De Prévia, Antoine, Mottay, Léo, Lawrance, Littisha, Belkouchi, Younes, Benatsou, Baya, Albiges, Laurence, Balleyguier, Corinne, Vera, Pierre, Lassau, Nathalie
Publicado 2023

Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume

por Belkouchi, Younes, Nebot-Bral, Laetitia, Lawrance, Littisha, Kind, Michele, David, Clémence, Ammari, Samy, Cournède, Paul-Henry, Talbot, Hugues, Vuagnat, Perrine, Smolenschi, Cristina, Kannouche, Patricia L., Chaput, Nathalie, Lassau, Nathalie, Hollebecque, Antoine
Publicado 2022

Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer

por Decazes, Pierre, Ammari, Samy, Belkouchi, Younes, Mottay, Léo, Lawrance, Littisha, de Prévia, Antoine, Talbot, Hugues, Farhane, Siham, Cournède, Paul-Henry, Marabelle, Aurelien, Guisier, Florian, Planchard, David, Ibrahim, Tony, Robert, Caroline, Barlesi, Fabrice, Vera, Pierre, Lassau, Nathalie
Publicado 2023